| RS2524435705 |
ALX3
|
Health Risk |
Pathogenic |
— |
| RS2524436507 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524436550 |
ALX3
|
Health Risk |
Pathogenic |
Frontorhiny, Frontorhiny |
| RS2524436642 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524439054 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524439055 |
SCP2
|
Health Risk |
Likely pathogenic |
— |
| RS2524439130 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524440255 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524440268 |
RPL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia |
| RS2524440290 |
RPL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524443241 |
VPS13D
|
Health Risk |
Pathogenic |
— |
| RS2524447545 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 6 |
| RS2524447634 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524447645 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524447710 |
RPL5
|
Health Risk |
Pathogenic |
— |
| RS2524447751 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524447807 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524447810 |
RPL5
|
Health Risk |
Conflicting classifications of pathogenicity |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 6 |
| RS2524448221 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524448276 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524448298 |
RPL5
|
Health Risk |
Likely pathogenic |
RPL5-related disorder, RPL5-related disorder |
| RS2524448314 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524448381 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524448571 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524448581 |
RPL5
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 6 |
| RS2524449692 |
P3H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524449933 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524450482 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524450808 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524451273 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524452224 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524452362 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524452384 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524452489 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS2524452544 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524452614 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524454786 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2524455111 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2524455153 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2524455621 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS2524456560 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524457676 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524458024 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524458087 |
RPL5
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 6, Diamond-Blackfan anemia 6 |
| RS2524458104 |
RPL5
|
Health Risk |
Pathogenic |
— |
| RS2524458148 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524458159 |
RPL5
|
Health Risk |
Pathogenic |
— |
| RS2524458707 |
OCA2
|
Health Risk |
Pathogenic |
Tyrosinase-positive oculocutaneous albinism, Tyrosinase-positive oculocutaneous albinism |
| RS2524462266 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524465398 |
P3H1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524469783 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524469917 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524470048 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524470295 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524471874 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524472523 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524473364 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524473865 |
RPL5
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2524474470 |
PARS2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 75 |
| RS2524477816 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS2524478879 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2524479569 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2524479833 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524484819 |
COL11A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 2, Stickler syndrome type 2 |
| RS2524490940 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524491217 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524491716 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524491905 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524492094 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524492246 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524492379 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524493095 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524496392 |
COL11A1
|
Health Risk |
Likely pathogenic |
— |
| RS2524497352 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS2524497850 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524498268 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524498281 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524498600 |
SCP2
|
Health Risk |
Pathogenic |
— |
| RS2524498793 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524498845 |
AGL
|
Health Risk |
Pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524499047 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524499198 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524499368 |
SCP2
|
Health Risk |
Pathogenic |
— |
| RS2524499650 |
VPS13D
|
Health Risk |
Likely pathogenic |
— |
| RS2524500585 |
STXBP3
|
Health Risk |
Likely pathogenic |
— |
| RS2524513732 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524514950 |
SLC35A3
|
Health Risk |
Pathogenic |
Autism spectrum disorder - epilepsy - arthrogryposis syndrome, Autism spectrum disorder - epilepsy - arthrogryposis syndrome |
| RS2524515643 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524515692 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524515927 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS2524516123 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524516472 |
DHDDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 59, Retinitis pigmentosa 59 |
| RS2524516667 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524516669 |
P3H1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type 8, Osteogenesis imperfecta type 8 |
| RS2524517066 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524517172 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524517271 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2524517535 |
DHDDS
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 59, Retinitis pigmentosa 59 |
| RS2524517770 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |
| RS2524517955 |
AGL
|
Health Risk |
Likely pathogenic |
Glycogen storage disease type III, Glycogen storage disease type III |